Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 32766875

Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2020 Dec 10
First author
Kim SJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2020 Dec 10;136(24):2721-2722. doi: 10.1182/blood.2020008360.
    note
    Source null
    related pmid
    33301035
    relationship
    Comment in

Authors and identifiers

  1. name
    Kim SJ
    type
    Author
  2. name
    Lim JQ
    type
    Author
  3. name
    Laurensia Y
    type
    Author
  4. name
    Cho J
    type
    Author
  5. name
    Yoon SE
    type
    Author
  6. name
    Lee JY
    type
    Author
  7. name
    Ryu KJ
    type
    Author
  8. name
    Ko YH
    type
    Author
  9. name
    Koh Y
    type
    Author
  10. name
    Cho D
    type
    Author
  11. name
    Lim ST
    type
    Author
  12. name
    Enemark MB
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Kim SJ
    type
    Author
  2. name
    Lim JQ
    type
    Author
  3. name
    Laurensia Y
    type
    Author
  4. name
    Cho J
    type
    Author
  5. name
    Yoon SE
    type
    Author
  6. name
    Lee JY
    type
    Author
  7. name
    Ryu KJ
    type
    Author
  8. name
    Ko YH
    type
    Author
  9. name
    Koh Y
    type
    Author
  10. name
    Cho D
    type
    Author
  11. name
    Lim ST
    type
    Author
  12. name
    Enemark MB
    type
    Author
bibliography ids
  1. nci-bib-75a358e479607af218bb2644
book metadata
content sha256
1168d8e174c96fb97b5240f76f50adffbd97665180bccd387fe2645f48c83fb2
document type
citation
dois
  1. 10.1182/blood.2020007247
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:32766875
immutable id
pubmed:32766875@1168d8e174c96fb97b5240f76f50adffbd97665180bccd387fe2645f48c83fb2
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
24
name
Blood
nlm unique id
7603509
pages
2754-2763
volume
136
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2020 Dec 10;136(24):2721-2722. doi: 10.1182/blood.2020008360.
    note
    Source null
    related pmid
    33301035
    relationship
    Comment in
outcomes validated
false
pmid
32766875
provenance
batch id
40d9eae1f1d369f13109
provider
NCBI PubMed ESummary
record sha256
4f370538a529be8de278b2a8066783230a223df7d7726ed9cc2d1c506e1a9131
response sha256
03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
retrieved at
2026-09-09T23:47:52.637547+00:00
publication date
display
2020 Dec 10
precision
day
year
2020
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32766875/
title
Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study.

Preserved source evidence · Independent clinical review pending · Not medical advice